These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The central diabetes insipidus associated with septo-optic dysplasia (de Morsier syndrome). Hetman M, Fułek M, Zajączkowska K, Żarczyńska A, Łagosz P, Barg E. Pediatr Endocrinol Diabetes Metab; 2018 Jun; 24(4):197-203. PubMed ID: 30963758 [Abstract] [Full Text] [Related]
6. Clinical, laboratory and neuroimaging profile of patient's cohort with septo-optic dysplasia treated at a pediatric university hospital. Braga TPC, Beserra ICR. J Pediatr (Rio J); 2024 Oct 10. PubMed ID: 39395814 [Abstract] [Full Text] [Related]
7. Neuroimaging Features in Children with Optic Nerve Hypoplasia and Septo-Optic-Pituitary Dysplasia. Salman MS, Hossain S, Rozovsky K. Can J Neurol Sci; 2024 May 10; 51(3):416-424. PubMed ID: 37492885 [Abstract] [Full Text] [Related]
8. Review of the MRI brain findings of septo-optic dysplasia. Ward DJ, Connolly DJA, Griffiths PD. Clin Radiol; 2021 Feb 10; 76(2):160.e1-160.e14. PubMed ID: 33019967 [Abstract] [Full Text] [Related]
9. Dynamic MRI in the congenital agenesis of the neural pituitary stalk syndrome: the role of the vascular pituitary stalk in predicting residual anterior pituitary function. Maghnie M, Genovese E, Villa A, Spagnolo L, Campan R, Severi F. Clin Endocrinol (Oxf); 1996 Sep 10; 45(3):281-90. PubMed ID: 8949565 [Abstract] [Full Text] [Related]
11. Delineating septo-optic dysplasia. Lubinsky M, Encha-Razavi F. Birth Defects Res; 2022 Dec 01; 114(20):1343-1353. PubMed ID: 36200678 [Abstract] [Full Text] [Related]
12. Posterior pituitary (PP) evaluation in patients with anterior pituitary defect associated with ectopic PP and septo-optic dysplasia. Secco A, Allegri AE, di Iorgi N, Napoli F, Calcagno A, Bertelli E, Olivieri I, Pala G, Parodi S, Gastaldi R, Rossi A, Maghnie M. Eur J Endocrinol; 2011 Sep 01; 165(3):411-20. PubMed ID: 21750044 [Abstract] [Full Text] [Related]
14. Spectrum of clinical presentations and endocrinological findings of patients with septo-optic dysplasia: a retrospective study. Cemeroglu AP, Coulas T, Kleis L. J Pediatr Endocrinol Metab; 2015 Sep 01; 28(9-10):1057-63. PubMed ID: 25879316 [Abstract] [Full Text] [Related]
15. Endocrine disorders in septo-optic dysplasia (De Morsier syndrome)--evaluation and follow up of 18 patients. Willnow S, Kiess W, Butenandt O, Dorr HG, Enders A, Strasser-Vogel B, Egger J, Schwarz HP. Eur J Pediatr; 1996 Mar 01; 155(3):179-84. PubMed ID: 8929724 [Abstract] [Full Text] [Related]
16. Presenting features and long-term effects of growth hormone treatment of children with optic nerve hypoplasia/septo-optic dysplasia. Vedin AM, Karlsson H, Fink C, Borchert M, Geffner ME. Int J Pediatr Endocrinol; 2011 Nov 15; 2011(1):17. PubMed ID: 22085631 [Abstract] [Full Text] [Related]
17. Risk factors in children with optic nerve hypoplasia and septo-optic dysplasia. Salman MS, Ruth CA, Yogendran MS, Rozovsky K, Lix LM. Dev Med Child Neurol; 2024 Jan 15; 66(1):106-116. PubMed ID: 37394738 [Abstract] [Full Text] [Related]
18. Gastroschisis and septo-optic-pituitary dysplasia: Is there an association? Salman MS, Ruth CA, Yogendran MS, Zrinyi A, Morris M. J Paediatr Child Health; 2024 Jul 15; 60(7):294-298. PubMed ID: 38780070 [Abstract] [Full Text] [Related]
19. Pituitary deficiencies related to optic nerve hypoplasia and visual acuity. Murray A, Schwartz T, Hornung L, Lawson S. Clin Endocrinol (Oxf); 2024 Nov 15; 101(5):507-515. PubMed ID: 39099207 [Abstract] [Full Text] [Related]